149 Bio has acquired 1 company, including 1 in the last 5 years.
149 Bio has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
1951 NW 7th Avenue, Suite 600,
Miami, Florida
33136
United States,
www.149bio.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2023-02-23 |
Gossamer Bio - Clinical Stage Integrin Activator Program · Life Science
San Diego, California Gossamer Bio's Clinical Stage Integrin Activator Program GB1275 has the potential to reduce innate immune cell driven autoimmunity in multiple therapeutic areas and significantly improve patients’ lives. Gossamer Bio's Clinical Stage Integrin Activator Program is based in San Diego, California. |
- | Divestiture |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
